The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2009
Filed:
Jul. 19, 2005
Balasingam Radhakrishnan, Chapel Hill, NC (US);
Diti Aggarwal, Raleigh, NC (US);
Michelle Ferro, Raleigh, NC (US);
Kenneth D. James, Mebane, NC (US);
Navdeep B. Malkar, Cary, NC (US);
Mark A. Miller, Raleigh, NC (US);
Leo Pavliv, Morrisville, NC (US);
Karen Polowy, Raleigh, NC (US);
Monica Puskas, Spring Hope, NC (US);
Nnochiri N. Ekwuribe, Cary, NC (US);
Balasingam Radhakrishnan, Chapel Hill, NC (US);
Diti Aggarwal, Raleigh, NC (US);
Michelle Ferro, Raleigh, NC (US);
Kenneth D. James, Mebane, NC (US);
Navdeep B. Malkar, Cary, NC (US);
Mark A. Miller, Raleigh, NC (US);
Leo Pavliv, Morrisville, NC (US);
Karen Polowy, Raleigh, NC (US);
Monica Puskas, Spring Hope, NC (US);
Nnochiri N. Ekwuribe, Cary, NC (US);
Biocon Ltd., , IN;
Abstract
Fatty acid compositions for administration of of pharmaceutical agents, such as proteins and peptides, protein and peptide conjugates, and/or cation-polypeptide conjugate complexes. In particular, the invention provides a solid pharmaceutical composition formulated for oral administration by ingestion, having from about 0.1 to about 75% w/w fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent. Further, the invention provides a liquid pharmaceutical composition formulated for oral administration by ingestion, comprising: from about 0.1 to about 10% w/v fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent.